Is the high risk of anaphylaxis to omalizumab a contraindication to this treatment?

Fiche du document

Auteurs

Date

2023

Discipline

Sociologie

Type de document

Articles

Périmètre

Publications

Langue

Français

Identifiant

handle: 10670/1.4lrffb

Source

European Journal of Dermatology

Collection

Organisation

Licence

Cairn

Sujets proches En

Therapy Anaphylactic reactions Reactions, Anaphylactic Anaphylactic shock Hypersusceptibility Shock, Anaphylactic

Citer ce document

Angelica Tiotiu et al., « Is the high risk of anaphylaxis to omalizumab a contraindication to this treatment? », European Journal of Dermatology, ID : 10670/1.4lrffb

Partage / Export

export

document thumbnail